Current use of biologic therapies for musculoskeletal disease: A survey of board‐certified equine specialists

OBJECTIVE: To evaluate the use of mesenchymal stem cells (MSCs), autologous conditioned serum (ACS), platelet‐rich plasma (PRP), and autologous protein solution (APS) for the treatment of equine musculoskeletal disease by diplomates of the American College of Veterinary Surgery (ACVS), and American...

Descripción completa

Detalles Bibliográficos
Autores principales: Knott, Lindsay E., Fonseca‐Martinez, B. Alexander, O'Connor, Annette M., Goodrich, Laurie R., McIlwraith, C. Wayne, Colbath, Aimee C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Article ‐ Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322007/
https://www.ncbi.nlm.nih.gov/pubmed/35383972
http://dx.doi.org/10.1111/vsu.13805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322007/
https://www.ncbi.nlm.nih.gov/pubmed/35383972
http://dx.doi.org/10.1111/vsu.13805

Ejemplares similares